Eusa Pharma - Business-News-Today.com

Business-News-Today.com

Business news, market intelligence, and global industry analysis.

Business-News-Today.com

The Latest

The hidden problem with GLP-1 weight loss and Veru Inc.’s bet to fix it (NASDAQ: VERU)

GRPN slides after Q4 revenue shortfall raises questions about Groupon’s turnaround durability

Harmony Gold Mining reports 61% operating profit surge but output decline and copper capex weigh on HMY stock

Can selective Bb inhibition give NovelMed Therapeutics an edge in the multibillion-dollar PNH drug market?

Read More

2 minute read

Pharma Industry News

Eusa Pharma completes $115m acquisition of Sylvant for iMCD treatment

Eusa Pharma has successfully acquired the global rights to Sylvant (siltuximab), a drug used in the treatment of…

bypharmanewsdaily

January 20, 2019

web analytics